Altogether, in order to achieve a prospective clinical application, COL1A2 and KRT19 might have a potential role as monitoring factors to screen early cancer, as well as prognostic factors predicting overall survival time, so this model could provide a new non-invasive option for the early detection and interception of tumors in population screening. Here, COL1A2 is linked to cancer.